BioCentury | May 12, 2008
Clinical News

Apo Triavir regulatory update

Apotex Inc. , Toronto, Product: Apo Triavir Business: Infectious Rwanda approved Apotex's HIV drug Apo-TriAvir under the Canadian Access to Medicines Regime (CAMR), which allows developing countries to import generic versions of patented drugs. Apo-TriAvir is...
BioCentury | Jul 30, 2007
Company News

Apotex, Rwanda's Government Centre for the Treatment & Research on AIDS infectious news

Rwanda plans to import 260,000 packs of Apotex's HIV drug Apo-TriAvir during the next two years, making Rwanda the first country to invoke the WTO's Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. Apo-TriAvir is...
Items per page:
1 - 2 of 2